GenMark Posts 300 Percent Q2 Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market Tuesday that its second-quarter revenues increased 300 percent due to growth in its test menu and reagents sold.

The Carlsbad, Calif.-based molecular diagnostics firm brought in total revenues of $3.6 million for the three months ended June 30, compared to $901,000 for the second quarter of 2011. It beat the consensus Wall Street estimate of $3.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.